ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (0R2M)

296.60
0.00
( 0.00% )
Updated: 19:00:00

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 4.86B5.87B6.71B7.86B8.78B16.12B12.26B13.12B
Operating Income 1.33B2.08B2.53B2.21B3.58B8.95B4.74B4.05B
Pre Tax Income 1.33B2.08B2.55B2.43B3.81B9.33B4.86B4.2B
Net Income 895.52M1.2B2.44B2.12B3.51B8.08B4.34B3.95B
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 4.1785.32410.7059.49216.24636.75719.58217.951
EBIT 1.34B2.1B2.58B2.34B3.67B9B4.8B4.03B
EBITDA 1.44B2.22B2.68B2.42B3.81B9.23B5.08B4.47B